- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Non-small cell lung cancer (NSCLC)
- Meeting Date: August 2019
- Public Summary Document (PSD) August 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) August 2019 PBAC Meeting - (Word 181KB)
Broad PBS subsidy listing for PD-(L)1 checkpoint inhibitors for non-small cell lung cancer – August 2019
Broad PBS subsidy listing for PD-(L)1 checkpoint inhibitors for non-small cell lung cancer
Last updated
9 July 2025